PetIQ, Inc. (NASDAQ:PETQ) Shares Purchased by SG Americas Securities LLC

SG Americas Securities LLC raised its stake in shares of PetIQ, Inc. (NASDAQ:PETQ) by 75.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,054 shares of the company’s stock after purchasing an additional 4,311 shares during the period. SG Americas Securities LLC’s holdings in PetIQ were worth $199,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Natixis Advisors L.P. acquired a new stake in shares of PetIQ in the first quarter worth $250,000. MetLife Investment Management LLC increased its position in shares of PetIQ by 60.7% in the first quarter. MetLife Investment Management LLC now owns 15,255 shares of the company’s stock worth $372,000 after acquiring an additional 5,762 shares in the last quarter. BlackRock Inc. increased its position in shares of PetIQ by 1.2% in the first quarter. BlackRock Inc. now owns 2,510,747 shares of the company’s stock worth $61,262,000 after acquiring an additional 29,457 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of PetIQ by 17.7% in the first quarter. Dimensional Fund Advisors LP now owns 631,142 shares of the company’s stock worth $15,399,000 after acquiring an additional 94,759 shares in the last quarter. Finally, Sei Investments Co. increased its position in shares of PetIQ by 18.7% in the first quarter. Sei Investments Co. now owns 235,346 shares of the company’s stock worth $5,732,000 after acquiring an additional 37,153 shares in the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group increased their price objective on shares of PetIQ from $24.00 to $28.00 and gave the stock a “buy” rating in a research report on Tuesday, March 19th. Four research analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $29.00.

PetIQ Price Performance

PETQ opened at $16.46 on Friday. The company has a fifty day simple moving average of $17.61 and a 200 day simple moving average of $18.51. The firm has a market cap of $484.42 million, a price-to-earnings ratio of 274.38 and a beta of 1.64. PetIQ, Inc. has a twelve month low of $10.82 and a twelve month high of $22.98. The company has a current ratio of 2.27, a quick ratio of 1.43 and a debt-to-equity ratio of 1.97.

PetIQ (NASDAQ:PETQ) last released its quarterly earnings results on Wednesday, February 28th. The company reported ($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.38) by $0.22. The business had revenue of $219.93 million during the quarter, compared to analyst estimates of $189.70 million. PetIQ had a net margin of 0.19% and a return on equity of 11.72%. Equities research analysts expect that PetIQ, Inc. will post 0.94 EPS for the current fiscal year.

About PetIQ

PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats.